Download file, English (1 MB PDF) - RHO

Other initiatives include the following:
• Development of national cervical cancer service delivery guidelines (started August 2010).
• Development of a national cervical cancer training package (started September 2010).
• Development of a national cervical cancer prevention and control strategy (started September
2010).
• Implementation of the strategy is slated to begin in July 2011.
Overview of Strategic Plan for Cervical Cancer Prevention and Control in
Uganda, 2010–2014
Dr. James Sekajugo
Principal Medical Officer, Non-communicable Diseases Program
Ministry of Health, Uganda
Dr. James Sekajugo reviewed the highlights of the recently developed Strategic Plan for Cervical Cancer
Prevention and Control in Uganda. Guiding the development of this document was a vision of Uganda
where all women are free of cervical cancer. The goals of the plan are to reduce HPV infection incidence
and prevalence; reduce cervical cancer incidence, prevalence, and mortality; and improve the quality of
life for cervical cancer survivors. Dr. Sekajugo noted that the strategic plan had important support from
the First Lady of Uganda and the MOH.
Specific goals to reach by 2015 are the following:
• 90% of Ugandans will have access to IEC materials about cervical cancer.
• 80% of girls aged 10 to 14 years will have access to HPV vaccine.
• 80% of women aged 30 to 55 years will have access to screening and treatment for
precancerous lesions and diagnostic services.
• 10% of invasive cervical cancer patients will have access to surgery.
• 65% of women with cervical cancer will have access to radiotherapy/chemotherapy services.
• 25% of cervical cancer patients will have access to palliative care services for improved quality of
life.
In addition, operations research should be conducted to guide the scheduling for screening programs to
ensure they are carried out in an efficient and cost-effective manner; to monitor women who have
received HPV vaccination and/or screening for cervical cancer for development of the disease; and to
monitor the outcome of treatment modalities for invasive cancer, including surgery, radiotherapy, and
palliative care.
Report of an African Regional Meeting on Cervical Cancer: September 2010 32